Volume 19 - Number 2

April - June 2017

The Revival of an “Old” Marker: CD4/CD8 Ratio

Giuseppe Bruno, Annalisa Saracino, Laura Monno and Gioacchino Angarano

Clinic of Infectious Diseases, University of Bari, Bari, Italy


The effectiveness of modern antiretroviral therapies transformed HIV infection into a chronic disease characterized by a persistent condition of inflammation and immune activation. For this reason, even though AIDS-related mortality has been reduced with an increased life expectancy, patients living with HIV infection are more likely to develop non-AIDS events despite the chievement of complete suppression of HIV replication. Hence, the scientific community feels the need to find new biomarkers, which would be suitable in clinical practice for identifying patients who require close monitoring because of an increased risk of developing comorbidities. A renewed interest has emerged about the usefulness of the CD4/CD8 ratio as a marker of immune activation and immune senescence. Recently, many studies have underlined that the CD4/CD8 ratio might represent a good predictor of AIDS and non-AIDS events. Herein, the potential role of the CD4/CD8 ratio for monitoring of HIV patients in different clinical settings is reviewed.

Key Words:

CD4/CD8 ratio. AIDS. ART. Chronic inflammation. Immune activation. Immune senescence.

Contact Us

Permanyer Publications

  • Mallorca, 310 Barcelona, Spain.  08037
Phone / Fax
  • +34 93 207 59 20
  • +34 93 457 66 42
  • permanyer@permanyer.com

     © 2017 Permanyer Publications  -  Legal Notice - Cookies Policy  -  ISSN 1139-6121- eISSN 1698-6997